论文部分内容阅读
北京以岭药业有限公司成立于2006年10月。其主营业务为专利中药新药及保健品的研发、生产和销售。是国家高新技术企业,同时也是国家专利试点企业、北京G2O工程企业和中关村首批“十百千”工程重点培育企业。公司董事长吴以岭院士曾获得国家技术发明二等奖在内的等5项国家大奖。北京以岭药业新药筛选中心是2010年在吴以岭院士指导下组建的一支新药发现团队。该团队自成立以来一直与国内外知名药物研发院所开展多种形式的研发
Beijing Yiling Pharmaceutical Co., Ltd. was established in October 2006. Its main business is research and development, production and sales of patented Chinese medicine and health products. Is a national high-tech enterprises, but also the national patent pilot enterprises, Beijing G2O engineering enterprises and the first batch of “Zhongguancun” “100” project focus on cultivating enterprises. Wu Yiling, chairman of the board has won the second prize of national technology inventions, including five national awards. Beijing Yiling Pharmaceutical New Drug Screening Center was set up in 2010 under the guidance of academicians Wu Yiling a new drug discovery team. Since its establishment, the team has been carrying out various forms of research and development with well-known pharmaceutical R & D institutes both at home and abroad